Telmisartan Jubilant 40mg Tablets Malte - anglais - Medicines Authority

telmisartan jubilant 40mg tablets

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - telmisartan - tablet - telmisartan 40 mg - agents acting on the renin-angiotensin system

Telmisartan Jubilant 80mg Tablets Malte - anglais - Medicines Authority

telmisartan jubilant 80mg tablets

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - telmisartan - tablet - telmisartan 80 mg - agents acting on the renin-angiotensin system

Telmisartan Teva Pharma Union européenne - anglais - EMA (European Medicines Agency)

telmisartan teva pharma

teva b.v. - telmisartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension in adults.

Telmisartan Actavis Union européenne - anglais - EMA (European Medicines Agency)

telmisartan actavis

actavis group ptc ehf - telmisartan - hypertension - agents acting on the renin-angiotensin system - hypertensiontreatment of essential hypertension in adults.cardiovascular preventionreduction of cardiovascular morbidity in patients with:manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or;type 2 diabetes mellitus with documented target organ damage.

Telmisartan Teva Union européenne - anglais - EMA (European Medicines Agency)

telmisartan teva

teva b.v. - telmisartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension in adults

Tolura Union européenne - anglais - EMA (European Medicines Agency)

tolura

krka, d.d., novo mesto  - telmisartan - hypertension - angiotensin ii antagonists, plain - hypertensiontreatment of essential hypertension in adults.cardiovascular preventionreduction of cardiovascular morbidity in patients with:manifest atherothrombotic cardiovascular disease (history of coronary heart disease or peripheral arterial disease) or;type 2 diabetes mellitus with documented target organ damage.